Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Return on Capital Employed (2018 - 2024)

Historic Return on Capital Employed for Solid Biosciences (SLDB) over the last 6 years, with Q3 2024 value amounting to 0.56%.

  • Solid Biosciences' Return on Capital Employed rose 900.0% to 0.56% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.56%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.53% for FY2023, which is 500.0% down from last year.
  • Per Solid Biosciences' latest filing, its Return on Capital Employed stood at 0.56% for Q3 2024, which was up 900.0% from 0.44% recorded in Q2 2024.
  • Solid Biosciences' Return on Capital Employed's 5-year high stood at 0.44% during Q2 2024, with a 5-year trough of 2.88% in Q3 2020.
  • Over the past 4 years, Solid Biosciences' median Return on Capital Employed value was 0.57% (recorded in 2023), while the average stood at 0.92%.
  • Within the past 5 years, the most significant YoY rise in Solid Biosciences' Return on Capital Employed was 1200bps (2020), while the steepest drop was -17500bps (2020).
  • Quarter analysis of 4 years shows Solid Biosciences' Return on Capital Employed stood at 1.09% in 2020, then skyrocketed by 53bps to 0.51% in 2022, then dropped by -27bps to 0.65% in 2023, then grew by 13bps to 0.56% in 2024.
  • Its Return on Capital Employed stands at 0.56% for Q3 2024, versus 0.44% for Q2 2024 and 0.51% for Q1 2024.